Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-06-26 @ 4:32 AM
Study NCT ID:
NCT07195734
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-24
First Post:
2025-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | View |
| None | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | View |
| None | Locally Recurrent Head and Neck Squamous Cell Carcinoma | View |
| None | Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma | View |
| None | Locally Recurrent Laryngeal Squamous Cell Carcinoma | View |
| None | Locally Recurrent Oral Cavity Squamous Cell Carcinoma | View |
| None | Locally Recurrent Oropharyngeal Squamous Cell Carcinoma | View |
| None | Stage II Laryngeal Cancer AJCC v8 | View |
| None | Stage II Lip and Oral Cavity Cancer AJCC v8 | View |
| None | Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | View |
| None | Stage III Laryngeal Cancer AJCC v8 | View |
| None | Stage III Lip and Oral Cavity Cancer AJCC v8 | View |
| None | Stage IVA Laryngeal Cancer AJCC v8 | View |
| None | Stage IVA Lip and Oral Cavity Cancer AJCC v8 | View |
| None | Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | View |
| None | Stage IVB Laryngeal Cancer AJCC v8 | View |
| None | Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | View |
Keywords: